Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $108.0800 (0.29%) ($106.5300 - $108.7500) on Thu. Sep. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.3% (three month average) | RSI | 22 | Latest Price | $108.0800(0.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -4.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(36%) XLP(34%) VYM(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.65% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-2%) TLT(-1%) TAN(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.65% (StdDev 1.3%) | Hourly BBV | 1 () | Intraday Trend | -0.1% | | | |
|
1 - 5 Day Possible Target | $99.21(-8.21%) | Resistance Level | $113.51 | 5 Day Moving Average | $107.3(0.73%) | 10 Day Moving Average | $108.59(-0.47%) | 20 Day Moving Average | $113.51(-4.78%) | To recent high | -10.5% | To recent low | 1.5% | Market Cap | $190.684b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |